Cargando…
The sensitivity and efficacy method of PIK3CA exon 9 E545A as a high diagnostic accuracy in breast cancer
The phosphatidylinositol 3-kinases (PIK3s) are lipid kinases. Mutation in the exon 9 and exon 20 determined as a predictive factor in anti-HER-2 therapy. In some countries, such as Singapore, China, and Peru, PIK3CA exon 9 E545A was reported to produce the highest rate of mutation. In this research,...
Autores principales: | Desriani, Al-Ahwani, Fuad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Scientific Research and Technology, Egypt
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296600/ https://www.ncbi.nlm.nih.gov/pubmed/30647707 http://dx.doi.org/10.1016/j.jgeb.2017.10.002 |
Ejemplares similares
-
Insights into the mechanism of the PIK3CA E545K activating mutation using MD simulations
por: Leontiadou, Hari, et al.
Publicado: (2018) -
Prevalence and prognostic role of PIK3CA E545K mutation in Iranian colorectal cancer patients
por: Ranjbar, Reza, et al.
Publicado: (2019) -
The E545K mutation of PIK3CA promotes gallbladder carcinoma progression through enhanced binding to EGFR
por: Zhao, Shuai, et al.
Publicado: (2016) -
Expression of PIK3CA mutant E545K in the mammary gland induces heterogeneous tumors but is less potent than mutant H1047R
por: Meyer, D S, et al.
Publicado: (2013) -
Phosphatidyl inositol-3 kinase (PIK3CA) E545K mutation confers cisplatin resistance and a migratory phenotype in cervical cancer cells
por: Arjumand, Wani, et al.
Publicado: (2016)